• Topics

  • Formats

As AI becomes increasingly integrated into healthcare systems, its potential applications in health technology assessment (HTA) are being actively explored. At the World Evidence, Pricing and Access Congress 2025, experts from HTA agencies, academia, and the pharmaceutical industry gathered during the session, “Rethinking added values of AI in HTA: debunking myths,” where they explored the current and future use of AI in HTA processes.

The session was chaired by Meindert Boysen (Independent HTA Expert & Chair, HTAi Global Policy Forum). He opened with an anecdote about attempting to count the number of AI-focused discussions at the congress using ChatGPT. “I asked ChatGPT how many sessions there were on AI… first it said 23, then 15,” he remarked, noting the challenge of obtaining consistent outputs from AI tools. “I think a quarter of our conversations here were in some way dealing with AI.”

Reading this content is completely free

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account

Join Now

You are attempting to log out of MyMA

Do you really want to log out?